| Original language | English (US) |
|---|---|
| Article number | 2003325 |
| Journal | European Respiratory Journal |
| Volume | 56 |
| Issue number | 5 |
| DOIs | |
| State | Published - Nov 1 2020 |
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: European Respiratory Journal, Vol. 56, No. 5, 2003325, 01.11.2020.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Face masks, respiratory patients and COVID-19
AU - Respiratory Effectiveness Group
AU - Soriano, Joan B.
AU - Anzueto, Antonio
AU - Anticevich, Sinthia Bosnic
AU - Kaplan, Alan
AU - Miravitlles, Marc
AU - Usmani, Omar
AU - Papadopoulos, Nikolaos G.
AU - Puggioni, Francesca
AU - Walter Canonica, G.
AU - Roche, Nicolas
N1 - Funding Information: Conflict of interest: J.B. Soriano has nothing to disclose. A. Anzueto reports personal fees for consultancy from GlaxoSmithKline, Boehringer Ingelheim and AstraZeneca, outside the submitted work. S. Bosnic Anticevich reports grants and personal fees for lectures and advisory board work from Teva, personal fees for lectures and advisory board work from AstraZeneca, personal fees for lectures and advisory board work from Boehringer Ingelheim, personal fees for lectures from GSK, personal fees for consultancy from Sanofi and Mylan, outside the submitted work. A. Kaplan has nothing to disclose. M. Miravitlles reports personal fees for lectures from AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Menarini, Rovi, Bial, Zambon, Sandoz, CSL Behring, Grifols and Novartis, personal fees for consultancy from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Bial, Gebro Pharma, CSL Behring, Laboratorios Esteve, Ferrer, Mereo Biopharma, Verona Pharma, Kamada, TEVA, Sanofi, pH Pharma, Novartis and Grifols, grants from GlaxoSmithKline and Grifols, outside the submitted work. O. Usmani has nothing to disclose. N.G. Papadopoulos has nothing to disclose. F. Puggioni reports personal fees from Sanofi, Novartis, GlaxoSmithKline, AstraZeneca, Chiesi, Menarini, Mundipharma, Boehringer, Valeas, Alk Abello and Allergy Therapeutics, outside the submitted work. G.W. Canonica has nothing to disclose. N. Roche has nothing to disclose.
PY - 2020/11/1
Y1 - 2020/11/1
UR - http://www.scopus.com/inward/record.url?scp=85096152229&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096152229&partnerID=8YFLogxK
U2 - 10.1183/13993003.03325-2020
DO - 10.1183/13993003.03325-2020
M3 - Letter
C2 - 32994197
AN - SCOPUS:85096152229
SN - 0903-1936
VL - 56
JO - European Respiratory Journal
JF - European Respiratory Journal
IS - 5
M1 - 2003325
ER -